Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis

Andersson S, Rylander E, Larsson B, Strand A, Silfversvard C, Wilander E (2001) The role of human papillomavirus in cervical adenocarcinoma carcinogenesis. Eur J Cancer 37: 246–250

Barbosa MS, Schlegel R (1989) The E6 and E7 genes of HPV-18 are sufficient for inducing two-stage in vitro transformation of human keratinocytes. Oncogene 4: 1529–1532

Bernard HU, Chan SY, Manos MM, Ong CK, Villa LL, Delius H, Peyton CL, Bauer HM, Wheeler CM (1994) Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms. J Infect Dis 170: 1077–1085

Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, Schiffman MH, Moreno V, Kurman R, Shah KV (1995) Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst 87: 796–802

Breslow NE, Day NE (1980) Statistical methods in cancer research. Vol. I – The analysis of case–control studies. IARC Sci Publ 32: 5–338

Burger RA, Monk BJ, Kurosaki T, Anton-Culver H, Vasilev SA, Berman ML, Wilczynski SP (1996) Human papillomavirus type 18: association with poor prognosis in early stage cervical cancer. J Natl Cancer Inst 88: 1361–1368

Chaouki N, Bosch FX, Munoz N, Meijer CJ, El Gueddari B, El Ghazi A, Deacon J, Castellsague X, Walboomers JM (1998) The viral origin of cervical cancer in Rabat, Morocco. Int J Cancer 75: 546–554

Chan SY, Delius H, Halpern AL, Bernard HU (1995) Analysis of genomic sequences of 95 papillomavirus types: uniting typing, phylogeny, and taxonomy. J Virol 69: 3074–3083

Chen S, O'Sullivan H, Tabrizi SN, Fairley CK, Quinn MA, Garland SM, (1999) Prevalence and genotyping of HPV in cervical cancer among Australian women. Int J Gynaecol Obstet 67: 163–168

Combita AL, Bravo M-M, Touze A, Coursaget P (2002) Serologic response to human oncogenic papillomavirus types 16,18,31,33,39,58 and 59 virus-like particles in Columbian women with invasive cervical cancer. Int J Cancer 97: 796–803

Davies P, Kornegay J, Iftner T (2001) Current methods of testing for human papillomavirus. Best Pract Res Clin Obstet Gynaecol 15: 677–700

Eluf-Neto J, Booth M, Munoz N, Bosch FX, Meijer CJ, Walboomers JM (1994) Human papillomavirus and invasive cervical cancer in Brazil. Br J Cancer 69: 114–119

Gravitt P, Hakenewerth A, Stoerker J (1991) A direct comparison of methods proposed for use in widespread screening of human papillomavirus infections. Mol Cell Probes 5: 65–72

Guerrero E, Daniel RW, Bosch FX, Castellsague X, Munoz N, Gili M, Viladiu P, Navarro C, Zubiri ML, Ascunce N, Gonzalez LC, Tafur L, Izarzugaza I, Shah KV (1992) Comparison of ViraPap, Southern hybridization, and polymerase chain reaction methods for human papillomavirus identification in an epidemiological investigation of cervical cancer. J Clin Microbiol 30: 2951–2959

Harima Y, Sawada S, Nagata K, Sougawa M, Ohnishi T (2002) Human papillomavirus (HPV) DNA associated with prognosis of cervical cancer after radiotherapy. Int J Radiat Oncol Biol Phys 52: 1345–1351

Hildesheim A, Hadjimichael O, Schwartz PE, Wheeler CM, Barnes W, Lowell DM, Willett J, Schiffman M (1999) Risk factors for rapid-onset cervical cancer. Am J Obstet Gynecol 180: 571–577

IARC Working Group on the Evaluation of Carcinogenic Risks to Humans (1995) Monographs on the evaluation of the carcinogenic risks to humans, Vol. 64, Human papillomaviruses. International Agency for Research on Cancer: Lyon: 64: 96–102

Illades-Aguiar B, Leyva-Vazquez MA, Alarcon-Romero LC, Alfaro-Flores E, Antonio-Veyar V, Lopez-Zamudio N, Teran-Porcayo MA (2000) Human papillomavirus infection in Mexican women with cervical cancer, squamous intraepithelial lesion and cytologically normal. Proceedings of the 18th International Papillomavirus Conference, Paris

Koutsky LA, Ault KA, Wheeler CM, Brown DR, Barr E, Alvarez FB, Chiacchierini LM, Jansen KU (2002) A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med 347: 1645–1651

Kleter B, van Doorn LJ, Schrauwen L, Molijn A, Sastrowijoto S, ter Schegget J, Lindeman J, ter Harmsel B, Burger M, Quint W (1999) Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus. J Clin Microbiol 37: 2508–2517

Liaw KL, Hildesheim A, Burk RD, Gravitt P, Wacholder S, Manos MM, Scott DR, Sherman ME, Kurman RJ, Glass AG, Anderson SM, Schiffman M (2001) A prospective study of human papillomavirus (HPV) type 16 DNA detection by polymerase chain reaction and its association with acquisition and persistence of other HPV types. J Infect Dis 183: 8–15

Lin P, Koutsky LA, Critchlow CW, Apple RJ, Hawes SE, Hughes JP, Toure P, Dembele A, Kiviat NB (2001) HLA Class II DR-DQ and increased risk of cervical cancer among Senegalese women. Cancer Epidemiol Biomarkers Prev 10: 1037–1045

Meyer T, Arndt R, Christophers E, Beckmann ER, Schroder S, Gissmann L, Stockfleth E, Gonzalez LC, Kaldor JM, Guerrero E, Lorincz A, Santamaria M, Alonso de Ruiz P, Aristizabal N, Shah KV (1998) Association of rare human papillomavirus types with genital premalignant and malignant lesions. J Infect Dis 178: 252–255

Munoz N, Bosch FX, de Sanjose S, Tafur L, Izarzugaza I, Gili M, Viladiu P, Navarro C, Martos C, Ascunce N, Gonzalez LC, Kaldor JM, Guerrero E, Lorincz A, Santamaria M, Alonso de Ruiz P, Aristizabal N, Shah KV (1992) The causal link between human papillomavirus and invasive cervical cancer: a population-based case–control study in Colombia and Spain. Int J Cancer 52: 743–749

Nakagawa S, Yoshikawa H, Onda T, Kawana T, Iwamoto A, Taketani Y (1996) Type of human papillomavirus is related to clinical features of cervical carcinoma. Cancer 78: 1935–1941

Nindl I, Arndt R, Schneede P, Enno C, Eggert S, Meyer T (2001) Low oncogenic potential of HPV53 examined in patients with normal cytology, condylomata acuminata, CIN and cervical cancer. Proceedings of the 19th International Papillomavirus Conference, Paris, Vol. 20

O'Leary JJ, Landers RJ, Crowley M, Healy I, O'Donovan M, Healy V, Kealy WF, Hogan J, Doyle CT (1998) Human papillomavirus and mixed epithelial tumors of the endometrium. Hum Pathol 29: 383–389

Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J (1997) Cancer Incidence in Five Continents, Vol. VII. IARC Scientific Publications No. 143. International Agency for Research on Cancer: Lyon

Parkin DM, Pisani P, Ferlay J (1999) Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 80: 827–841

Pirog EC, Kleter B, Olgac S, Bobkiewicz P, Lindeman J, Quint WG, Richart RM, Isacson C (2000) Prevalence of human papillomavirus DNA in different histological subtypes of cervical adenocarcinoma. Am J Pathol 157: 1055–1062

Qu W, Jiang G, Cruz Y, Chang CJ, Ho GY, Klein RS, Burk RD (1997) PCR detection of human papillomavirus: comparison between MY09/MY11 and GP5+/GP6+ primer systems. J Clin Microbiol 35: 1304–1310

Rabelo-Santos SH, Magalhaes AV, Amaral RG (2001) Human papillomavirus DNA prevalence among women with CIN III and invasive cancer. Proceedings of the 19th International Papillomavirus Conference

Roda Husman AM, Walboomers JM, van den Brule AJ, Meijer CJ, Snijders PJ (1995) The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 76: 1057–1062

Sasieni P, Adams J (2001) Changing rates of adenocarcinoma and adenosquamous carcinoma of the cervix in England. Lancet 357: 1490–1493

Schiffman MH, Bauer HM, Lorincz AT, Manos MM, Byrne JC, Glass AG, Cadell DM, Howley PM (1991) Comparison of Southern blot hybridisation and polymerase chain reaction methods for the detection of human papillomavirus DNA. J Clin Microbiol 29: 573–577

Schwartz SM, Daling JR, Shera KA, Madeleine MM, McKnight B, Galloway DA, Porter PL, McDougall JK (2001) Human papillomavirus and prognosis of invasive cervical cancer: a population-based study. J Clin Oncol 19: 1906–1915

Sebbelov AM, Davidson M, Kruger KS, Jensen H, Gregoire L, Hawkins I, Parkinson AJ, Norrild B (2000) Comparison of human papillomavirus genotypes in archival cervical cancer specimens from Alaska natives, Greenland natives and Danish Caucasians. Microbes Infect 2: 121–126

Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Munoz N (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189: 12–19

White H (1980) A heteroskedasticity-consistent covariance matrix estimator and a direct test for heteroskedasticity. Econometrica 48: 817–830

Wong YF, Cheung TH, Chan MK, Poon CS, Chung TK (2000) Prevalence and genotype of human papillomavirus in cervical carcinoma: a nationwide perspective in China. Proceedings of the 18th International Papillomavirus Conference, Paris

Yang YC, Shen J, Tate JE, Wang KG, Su TH, Wang KL, Jeng CJ, Chen HS, Chiang S, Crum CP (1997) Cervical cancer in young women in Taiwan: prognosis is independent of papillomavirus or tumor cell type. Gynecol Oncol 64: 59–63